Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

Lacklustre ASX declines 0.3% as RBA holds steady

ASX falls but 2% higher in May, Macquarie, Magellan looking to the future The ASX200 (ASX: XJO) fell 0.3% on Tuesday, the first day of winter, with consumer confidence taking a hit as the Victorian lockdown rolls on. Every sector was weaker except energy and materials, which added 1.3% and 0.3% respectively. Healthcare and financials were the…

The Inside Investor | 1st Jun 2021 | More
ASX adds 0.3% as banks and miners rise

Another positive week, tech continues disappearing act, Macquarie delivers record profit  The ASX200 (ASX:XJO) managed to deliver another positive week, adding 0.3% on Friday and 0.8% for the week. The news of the week was the Chinese Government ceasing high level discussions with Australian officials, but at the same time, their demand sends the iron ore price to a record above…

The Inside Investor | 9th May 2021 | More
ASX set for seventh month of straight gains

Mixed day but higher finish, new highs for stalwarts, Woolworths disappoints The ASX200 (ASX:XJO) managed another small gain, adding 0.3%, powered ahead by the technology sector; Afterpay (ASX”APT) and Zip Co (ASX:Z1P) adding 3.5% and 2.5% respectively. With half the sectors down, it was the consumer businesses that were the biggest detractors, Woolworths (ASX:WOW) falling 3.9% after delivering lackluster third quarter sales figures….

The Inside Investor | 29th Apr 2021 | More
  • ASX200 lower on bond rates

    ASX200 lower on bond rates, Crown (ASX:CWN) to face commission, Costa Group (ASX:CGC) boosted by avocados  The ASX200 finished 0.2% lower on a mixed day for the market, with resources and materials leading the way adding 2.6% ahead of a bumper dividend season. Most of the weakness came from the healthcare and IT sectors as the 10-year…

    The Inside Investor | 22nd Feb 2021 | More
    ASX update; COVID-19 impacting Macquarie Group

    Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…

    Drew Meredith | 14th Sep 2020 | More